Search

Your search keyword '"Moreno, K."' showing total 399 results

Search Constraints

Start Over You searched for: Author "Moreno, K." Remove constraint Author: "Moreno, K."
399 results on '"Moreno, K."'

Search Results

201. Virus-Based Nanoreactors with GALT Activity for Classic Galactosemia Therapy.

202. Influence of Positional Isomerism on the Chiroptical Properties of Functional Aromatic Oligoamide Foldamers.

203. Adjuvant electrochemotherapy after debulking in canine bone osteosarcoma infiltration.

204. Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity.

205. COVID-19: Clouds Over the Antimicrobial Resistance Landscape.

206. Camouflaged, activatable and therapeutic tandem bionanoreactors for breast cancer theranosis.

207. Nanotoxicological study of downconversion Y 2 O 3 :Eu 3+ luminescent nanoparticles functionalized with folic acid for cancer cells bioimaging.

208. Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.

209. Electrospun Fibers and Sorbents as a Possible Basis for Effective Composite Wound Dressings.

210. High Phenotypic and Genotypic Diversity of Enterococcus faecium from Clinical and Commensal Isolates in Third Level Hospital.

211. Multimaterial 3D Printing for Microrobotic Mechanisms.

212. Hyper-Rayleigh Scattering as a New Chiroptical Method: Uncovering the Nonlinear Optical Activity of Aromatic Oligoamide Foldamers.

213. Antimicrobial resistance and antibiotic consumption in Mexican hospitals.

214. Vertigo in patients with cancer: Red flag symptoms.

215. Carnivore Protoparvovirus 1 at the Wild-Domestic Carnivore Interface in Northwestern Mexico.

216. Aromatic oligoamide foldamers as versatile scaffolds for induced circularly polarized luminescence at adjustable wavelengths.

217. Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports.

218. A late Pleistocene human footprint from the Pilauco archaeological site, northern Patagonia, Chile.

219. Dual-photosensitizer coupled nanoscintillator capable of producing type I and type II ROS for next generation photodynamic therapy.

220. Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study.

221. Optical stimulation of cardiac cells with a polymer-supported silicon nanowire matrix.

222. Nocardia Otitidiscaviarum Infection in an Immunocompetent Patient.

223. Fatness and Fluctuating Body Weight: Effect on Central Vasculature.

224. Light sheet microscopy and SrAl 2 O 4 nanoparticles codoped with Eu 2+ /Dy 3+ ions for cancer cell tagging.

225. Myasthenia gravis as a prognostic marker in patients with thymoma.

226. Radiotherapy induced cavernomas in adult cancer patients.

227. Antifungal activity of avocado rhizobacteria against Fusarium euwallaceae and Graphium spp., associated with Euwallacea spp. nr. fornicatus, and Phytophthora cinnamomi.

228. Inactivity and Its Associated Factors in Adults Scheduled for Noncardiac Surgery: The PAMP Phase I Study.

229. Validation of Central and Peripheral Non-Invasive Hemodynamic Variables Using an Oscillometric Method.

230. Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer.

231. Differential influences of allometry, phylogeny and environment on the rostral shape diversity of extinct South American notoungulates.

232. Kaposi sarcoma incidence in females is nearly four-fold higher in the Lower Rio Grande Valley compared to the Texas average.

233. [Frequency of successful aging and frailty. Associated risk factors].

234. Using 3 Tesla magnetic resonance imaging in the pre-operative evaluation of tongue carcinoma.

235. Comparison of cytotoxicity and genotoxicity effects of silver nanoparticles on human cervix and breast cancer cell lines.

236. Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter?

237. Biocatalytic virus capsid as nanovehicle for enzymatic activation of Tamoxifen in tumor cells.

238. Cytochrome P450 Bioconjugate as a Nanovehicle for Improved Chemotherapy Treatment.

239. A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies.

240. Prevalence and Phylogenetic Analysis of Bartonella Species of Wild Carnivores and Their Fleas in Northwestern Mexico.

241. Effect of silver nanoparticles on the metabolic rate, hematological response, and survival of juvenile white shrimp Litopenaeus vannamei.

242. Differences by Altitude in the Frequency of Congenital Heart Defects in Colombia.

243. The social structure of Golfo Dulce bottlenose dolphins ( Tursiops truncatus ) and the influence of behavioural state.

244. Aminosilane Functionalization and Cytotoxicity Effects of Upconversion Nanoparticles Y 2 O 3 and Gd 2 O 3 Co-Doped with Yb 3+ and Er 3 .

245. Xerostomia Among Older Adults With Low Income: Nuisance or Warning?

246. Antioxidant Capacity of Poly(Ethylene Glycol) (PEG) as Protection Mechanism Against Hydrogen Peroxide Inactivation of Peroxidases.

247. Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery.

248. EPR and LC-MS studies on the mechanism of industrial dye decolorization by versatile peroxidase from Bjerkandera adusta.

249. Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.

250. Potential cross-reactivity of monoclonal antibodies against clinically relevant mycobacteria.

Catalog

Books, media, physical & digital resources